Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

October 8, 2020

Linda Clark and Brad Gallagher Write for Pharmacy Insider Blog

Linda Clark, Health Care Controversies Team leader, and Brad Gallagher, counsel, wrote a blog post called “Pharmacies Beware: PBM ‘Concerns’ and ‘Suspicions’ Lead to Network Terminations in Lead Up to SCOTUS Showdown” for The Pharmacy Insider. The post noted:

Pharmacy benefit managers (PBMs) are on the offensive. In recent weeks, PBMs have been aggressively auditing and terminating community pharmacies from their networks, sometimes with limited due process and for relatively minor findings. The practical impact is that these terminations trigger patient communications that often steer patients to the PBMs’ own affiliated pharmacies. . . While advocating for fairness and patient rights, your pharmacy must continue to understand its PBM agreements and associated provider manuals, amendments, and updates that are often faxed, emailed, or placed on a PBMs portal that, for the most part, govern the terms and conditions of your network participation. A pharmacy that does not have a policy to routinely check for changes and continually train its staff is setting itself up for a potentially catastrophic termination and recoupment scenario that could prove be a business and professional disaster.

Read the full post here.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Federal Judge Halts DOE's Crackdown on Diversity Programs

Alerts

Alternative Dispute Resolution: A Beginner's Guide to Arbitration, Mediation, and Settlement Conferences

Alerts

IRS Guidance Limits the Use of Five Percent Safe Harbor to Low-Output Solar Facilities

Alerts

New York Public Service Commission Denies New York Power Authority Petition to Designate Clean Path Transmission Project a Priority Transmission Project

Alerts

NYS Legislature Seeks to Restrict Time Period for Third-Party Actions

Alerts

United States Department of Justice Issues Antidiscrimination Guidance to Federal Funding Recipients